CN Patent

CN101891596B — 一种化合物及其制备方法和用途

Assigned to Shanghai Techwell Biopharmaceutical Co Ltd · Expires 2013-12-11 · 12y expired

What this patent protects

本发明公开了一种新的化合物及其制备方法和用途。所述的新化合物如式I所示。

USPTO Abstract

本发明公开了一种新的化合物及其制备方法和用途。所述的新化合物如式I所示。

Drugs covered by this patent

treprostinil-diolamine (TREPROSTINIL DIOLAMINE)

Patent Metadata

Patent number: CN101891596B
Jurisdiction: CN
Classification: —
Expires: 2013-12-11
Drug substance claim: No
Drug product claim: No
Assignee: Shanghai Techwell Biopharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.